BioSpace News Archive

Mr. d’Esparbes will oversee all financial functions as Progenity develops its proprietary precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms.

Back in Motion Physical Therapy, a leading provider of physical therapy that benefits patients and healthcare providers, is pleased to announce that it has moved to a new outpatient rehabilitation clinic in Newport, Maine.

Cryoport, Inc. announced its Chief Executive Officer, Jerrell Shelton, and other members of the management team, will ring the Nasdaq closing bell on Monday, June 10, 2019.

Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies

First Potential Treatment Demonstrating Substantial Reduction in the Frequency of Porphyria Attacks

This makes the bFed System the first tube feeding delivery system to be available without a prescription.

This integration, through Apple Health, will allow users to automatically integrate their insulin data with the Glooko diabetes data management system for clinical evaluation by their healthcare professionals.

Provident Healthcare Partners served as exclusive financial advisor to DEA.

Medicomp’s Quippe solution earns perfect rating on customer experience, performance, value and other criteria

Aqualung scientists identified nicotinamide phosphoribosyltransferase as a novel upstream immune-based therapeutic target in the development of Acute Respiratory Distress Syndrome, their lead clinical indication. They have developed eNamptor™, a humanized monoclonal antibody designed to neutralize circulating extracellular eNAMPT, as a novel biologic to suppress lung and systemic inflammatory cascades.